2Bermudez EA,Rifai N,Buring J,Manson JE,Ridker PM.Interrelationship among circulating interleukin-6,C-reactive protein,and traditional cardiovascular risk factors in women.Arterioscler Tromb Vasc Biol,2002,22:1 668-673
3Nelken NA,Coughlin SR,Gordon D,Wilcox JN.Monocyte chemoattractant protein-1 in human atheromatous plaques.J Clin Invest,1991,88:1 121-127
4Ridker PM,Rifai N,Clearfield M,Downs JR,Weis SE,Miles JS,et al.Measurement of C-reactive proteinfor the targeting of statin therapy in the primary prevention of acute cornary events.N Engl J Med,2001,344:1 959-965
5Musial J,Undas A,Gajewski P,Jankowski M,Sydor W,Szcezklik A.Anti-inflammatiory effects of simvasatin in subjects with hypercholesterolemia.Int J Cardiol,2001,77:247-253
6Han SN,Leka LS,Lichtenstein AH,Ausman LM,Schaefer EJ,Meydani SN.Effect of hydrogenated and saturated,relative to polyunsaturated,fat on immune and inflammatory responses of adults with moderate hypercholesterolemia.J Lipid Res,2002,43 (3):445-452
7Namik M,Kawashima S,Yamashita T,Ozaki M,Hirase T,et al.Local overexpression of monocyte chemoattrractant protein-1 at vessel wall induces infiltration of macrophages and formation of atherosclerotic lesion.Arterioscler Thromb Vas Biol,2002,22:115-120
8Jovinge S,Ares MPS,Kallin B,Nilsson J.Human moncytes macrophages release TNF-α in response to ox-LDL.Arterioscler Thromb Vasc Biol,1996,16:1 573-579
10Plenge JK,Hernandez TL,Weil KM,Poirier P,Grunwald GK,Marcovina SM,et al.Simvastatin lowers C-reactive protein within 14 days an effect independent of low-density lipoprotein cholesterol reduction.Circulation,2002,106:1 447-452
